Penka Petrova, Chief Development Officer at Trillium Therapeutics Inc. (TRIL), sold 11,132 shares at $12.65 ($142K) on 2021-02-08, disclosed to the SEC on 2021-02-10.
Open-market sale of $142k TRIL by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.65 | 5,312 | $67K | 47.5% |
| 2 | $12.65 | 5,312 | $67K | 47.5% |
| 3 | $14.17 | 508 | $7K | 5.1% |
| Total | $12.72 avg | 11,132 | $142K | 100% |
| Filing → |
| TRIL | SELL | 2021-01-13 | $8K | — | Filing → |
| TRIL | SELL | 2021-01-12 | $40K | — | Filing → |
| TRIL | SELL | 2021-01-11 | $40K | — | Filing → |